The increasing prevalence of neurological disorders, rising demand for advanced therapies, and continuous innovation in pharmaceutical research are accelerating growth across brain disorder treatment, neuroscience pharmaceuticals, CNS drug development, and the US neurology therapeutics market. Neurological conditions such as Alzheimer’s disease, Parkinson’s disease, epilepsy,...